Microsoft word - hit-rez 2005_v6amend3_protokoll_10.03.11.doc

20. Literaturverzeichnis
Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-
C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85(5): 365-
376
Abrey LE, Rosenblum MK, Papadopoulos E, et al. High dose chemotherapy with autologous stem cell rescue in adults with malignant primary brain tumors. J Neurooncol 1999; 44 (2): 147-153 Adamson PC, Balis FM, Arndt CA, et al. Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic study. Cancer Res 1991; 51 (22): 6079-6083 Aggarwal R, Yeung D, Kumar P, et al. Efficacy and feasibility of stereotactic radio-surgery in the primary management of unfavorable pediatric ependymoma. Radiother Oncol 1997; 43: 269-273 Akay KM, Izci Y, Baysefer A, et al. Surgical outcomes of cerebellar tumors in children. Pediatr Neurosurg 2004; 40(5): 220-225 Allen JC, Helson L. High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J Neurosurg 1981; 55: 749-756 Allen JC, Epstein F. Medulloblastoma and other primary malignant tumors of the CNS. J Neurosurg 1982; 57: 446-452 Allen JC, Walker R, Luks E, et al. Carboplatin and recurrent childhood brain tumors. J Clin Oncol 1987; 5: 459-463 Balon HR, Goldsmith SJ, Siegel BA, et al. Society of Nuclear Medicine Procedure Guideline for Somatostatin Receptor Scintigraphy with In-111 Pentetreotide; version 1.0, approved February 21st, 2001. Balter-Seri J, Mor C, Shuper A, et al. Cure of recurrent medulloblastoma: the contribution of surgical resection at relapse. Cancer 1997; 79 (6): 1241-1247 Becker LE, Hinton D. Primitive neuroectodermal tumors of the central nervous system. Human Pathol 1983; 14: 538-550 Belza MG, Donaldson SS, Steinberg GK, et al. Medulloblastoma: freedom from relapse longer than 8 years - a therapeutic cure? J Neurosurg 1991; 75 (4): 575-582 Berg SL, Balis FM, Zimm S, et al. Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies. J Clin Oncol 1992; 10 (1): 143-148 Berry MP, Jenkin RD, Colin MB, et al. Radiation treatment for medulloblastoma. A 21-year review. J Neurosurg 1981; 55: 43-51 Blaney SM, Poplack DG. New cytotoxic drugs for intrathecal administration. J Neurooncol 1998; 38: 219-223 Bleyer WA, Poplack DG, Simon RM. "Concentration x time" methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms. Blood 1978; 51: 835-842 Bloom HJG. The role of adjuvant chemotherapy in the primary treatment of medulloblastoma and ependymoma. In: Pochedly C (ed.). Controversies in pediatric and adolescent hematology and oncology. CV Mosby, St. Louis, 1989 B. Borgelt et al. Int J Radiat Oncol Biol Phys 1980; 6: 1-9 (6)). The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Broniscer A, Nicolaides TP, Dunkel IJ, et al. High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors. Pediatr Blood Cancer 2004; 42 (3): 261-267 Busca A, Miniero R, Besenzon L, et al. Etoposide-containing regimens with autologous bone marrow transplantation in children with malignant brain tumors. Childs Nerv Syst 1997; 13 (11-12): 572-577 Calaminus G, Ittner E, Neubauer M, et al. Prospective evaluation of late effects and quality of life (QOL) in patients with ALL and brain tumors in Germany. Med Pediatr Oncol 2002; 39: 345 Calaminus G, Weinspach S, Teske C, Göbel U. Quality of life in children and adolescents with cancer. First results of an evaluation of 49 patients with the PEDQOL questionaire. Klin Pädiatr 2000; 212(4): 211-215 Castello MA, Clerico A, Deb G, et al. High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors. Am J Pediatr Hematol Oncol 1990; 12 (3): 297-300 Cereda C, Calaminus G, Varotto S, et al. Searching for a tool to assess quality of life (QOL) in childhood cancer survivors – results of the PEDQOL in a cohort of italian children and adolescents. Med Pediatr Oncol 2003; 41: 271 Version 6: 10.03.2011, inkl. 3. Amendment Cinatl J, Kotchetkov R, Blaheta R, et al., Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha. Int J Oncol 2002; 20 (1): 97-106 Chamberlain MC, Prados MD, Silver P, et al. A phase II trial of oral melphalan in recurrent primary brain tumors. Am J Clin Oncol 1988; 11 (1): 52-54 Chamberlain MC, Kormanik PA. Chronic oral VP-16 for recurrent medulloblastoma. Pediatr Neurol 1997a; 17 (3): 230-234 Chamberlain MC. Pediatric leptomeningeal metastases: outcome following combined therapy. J Child Neurol 1997b; 12: 53-59 Chamberlain MC. Radioisotope CSF flow studies in leptomeningeal metastases. J Neurooncology 1998; 38: 135-140 Chamberlain MC. Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide. Pediatr Neurol 2001; 24 (2): 117-121 Chang CH, Housepian EM, Herbert C Jr. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 1969; 93: 1351-359 Cohen, BH, Packer RJ. Chemotherapy for medulloblastomas and primitive neuroectodermal tumors. J Neurooncol 1996; 29: 55-68 Dallorso S, Manzitti C, Morreale G, et al. High dose therapy and autologous hematopoietic stem cell transplantation in poor risk solid tumors of childhood. Haematologica 2000; 85 (11 Suppl): 66-70 Das A, Banik NL, Patel SJ, Ray SK. Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities. Mol Cancer 2004; 3(1): 36 Däumling E, Dierksen A, Wolff J, Jürgens H: FMH, a new instrument to measure quality of life. Klin Pädiatr 1994; 206: 351 Davidson A, Gowing R, Lowis S, et al. Phase II study of 21 day schedule oral etoposide in children. New Agents Group of the United Kingdom Children's Cancer Study Group (UKCCSG). Eur J Cancer 1997; 33 (11): 1816-1822 DeAngelis LM. Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol 1998; 38: 245-252 Dunbar SF, Tarbell NJ, Kooy HM, Alexander E 3rd, Black PM, Barnes PD, Goumnerova L, Scott RM, Pomeroy SL, La Vally B. Stereotactic radiotherapy for pediatric and adult brain tumors: preliminary report. Int J Radiat Oncol Biol Phys 1994; 30 (3): 531-539 Duffner PK, Cohen ME. Extraneural metastases in childhood brain tumors. Ann Neurol 1981; 10: 261-265 Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. New Engl J Med 1993; 328: 1725-1731 Dunkel IJ, Finlay JL. High dose chemotherapy with autologous stem cell rescue for patients with medulloblastoma. J Neurooncol 1996; 29: 69-74 Dunkel IJ, Boyett JM, Yates A, et al. High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group. J Clin Oncol 1998; 16: 222-228 Dupuis-Girod S, Hartmann O, Benhamou E, et al. Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma? J Neurooncol 1996; 27: 87-98 Evans AE, Jenkin RDT, Sposto R, et al. The treatment of medulloblastoma: Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 1990; 72: 572-582 Farina P, Marzillo G, D'Incalci M. High-performance liquid chromatography determination of 4'-demethyl-epipodophyllotoxin-9-(4,6-O-ethylidene beta-D-glucopyranoside) (VP 16-213) in human plasma. J Chromatogr 1981; 222: 141-145 Fazekas F. Magnetic resonance signal abnormalities in asymptomatic individuals: their incidence and functional correlates. Eur Neurol 1989; 29 (3):164-168 Finlay JL. The role of high-dose chemotherapy and stem cell rescue in treatment of malignant brain tumors: a reappraisal. Pediatr Transplant 1999; 3 Suppl1: 87-95 Finlay, J. L., S. Goldman, M. C. Wong, et al. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group. J Clin Oncol 1996; 14: 2495-2503 Version 6: 10.03.2011, inkl. 3. Amendment Fleischhack G, Reif S, Hasan C, et al. Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumors. Br J Cancer 2001; 84: 1453-1459 Frühwald MC, Rickert CH, O'Dorisio MS, et al. Somatostatin receptor subtype 2 is expressed by supratentorial primitive neuroectodermal tumors of childhood and can be targeted for somatostatin receptor imaging. Clin Cancer Res 2004; 10 (9): 2997-3006 Gajjar A, Kühl J, Epelman S, et al. Chemotherapy of medulloblastoma. Childs Nerv Syst 1999; 15 (10): 554-562 Gardner S, Baker D, Belasco J, et al. Phase I dose escalation of temozolomide with thiotepa and carboplatin with autologous stem cell rescue (ASCR) in patients with recurrent/refractory central nervous system (CNS) tumors. 11th International Symposium on Pediatric Neuro-Oncology, Boston, 13th-16th June 2004 (abstr) Gaze MN, Smith DB, Rampling RP, et al. Combination chemotherapy for primitive neuroectodermal and other malignant brain tumours. Clin Oncol (R Coll Radiol) 1994; 6 (2): 110-115 Gentet JC, Doz F, Bouffet E, et al. Carboplatin and VP-16 in medulloblastoma: A phase II study of the French Study of Pediatric Oncology (SFOP). Med Ped Oncol 1994; 23: 422-427 Geyer JR, Zeltzer PM, Boyett JM, et al. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: A report from the Childrens Cancer Group. J Clin Oncol 1994; 12: 1607-1615 Goldwein JR, Leahy JM, Packer RJ, et al. Intracranial ependymomas in children. Int J Radiat Oncol Biol Phys 1990; 19: 1497-1502 Goodman R. The extended version of the Strengths and Difficulties Questionnaire as a guide to child psychiatric caseness and consequent burden. J Child Psychol Psychiatry 1999; 40(5): 791-800 Grabb PA, Lunsford LD, Albright AL, et al. Stereotactic radiosurgery for glial neoplasms of childhood. Neurosurgery 1996; 38 (4): 696-701; discussion 701-702 Graham ML, Herndon JE, Casey JR, et al. High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors. J Clin Oncol 1997; 15: 1814-1823 Grill J, Kalifa C, Doz F, et al. A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study. Pediatr Neurosurg 1996; 25: 7-12 Groll AH, Walsh TJ. Antifungal Chemotherapy: Recent advances and current perspectives. Swiss Medical Weekly 2002; 132: 303-311 Gururangan S, McLaughlin C, Quinn J, et al. High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas. J Clin Oncol 2003; 21 (11): 2187-2191 Hande KR, Wedlund PJ, Noone RM, et al. Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients. Cancer Res 1984; 44: 379-382 Hansen HH, Muggia FM. Treatment of malignant brain tumors with nitrosoureas. Cancer Chemother Rep 1971; 55 (2): 99-100 Harisiadis L, Chang CH. Medulloblastoma in children: a correlation between staging and results of treatment. Int J Radiat Oncol Biol Phys 1977; 2: 833-841 Henwood JM, Brogden RN. Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer. Drugs 1990; 39: 438-490 Hodgson DC, Goumnerova LC, Loeffler JS, et al. Radiosurgery in the management of pediatric brain tumors. Int J Radiat Oncol Biol Phys 2001; 50 (4): 929-935 Hongeng S, Visudtibhan A, Dhanachai M, et al. Treatment of leptomeningeal relapse of medulloblastoma with temozolomide. J Pediatr Hematol Oncol 2002; 24 (7): 591-593 Hughes EN, Shillito J, Sallan SE, et al. Medulloblastoma at the Joint Center for Radiation Therapy between 1968 and 1984. Cancer 1988; 61: 1992-1998 Hughes WT; Armstrong D, Bodey GP, et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730–751 Jaeckle KA, Hess KR, Yung WK, et al. North American Brain Tumor Consortium. Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study. J Clin Oncol 2003; 21 (12): 2305-2311 Jennison, C, Turnbull B. Group sequential methods with applications to clinical trials. London, Chapman & Hall. 2000; chapter 5.2: 111-123 Version 6: 10.03.2011, inkl. 3. Amendment Kaatsch P, Rickert CH, Kühl J, et al. Population-based epidemiologic data on brain tumors in German children. Cancer 2001; 92 (12): 3155-3164 Kalifa C, Flamant F, Hartmann O, et al. Postsurgical chemotherapy without radiation therapy in patients less than three years with malignant brain tumors. Pediatr Neurosci 1988; 14: 163 (abstr) Kalifa C, Valteau D, Pizer B, et al. High-dose chemotherapy in childhood brain tumours. Childs Nerv Syst 1999; 15: 498-505 Kellie SJ. Chemotherapy of central nervous system tumours in infants. Childs Nerv Syst 1999; 15 (10): 592-612 Kennedy C, Calaminus G. A comparison between two quality of life measures in survivors of brain tumors or leukaemia in childhood and adolescents. Med Pediatr Oncol 2002; 39: 345 Kim S, Chatelut E, Kim JC, et al. Extended CSF cytarabine exposure following intrathecal administration of DTC 101. J Clin Oncol 1993; 11 (11): 2186-2193 Kiya K, Uozumi T, Ogasawara H, et al. Penetration of etoposide into human malignant brain tumors after intravenous and oral administration. Cancer Chemother Pharmacol 1992; 29: 339-342 Kleihues P, Cavenee WK. World Health Organization Classification of Tumours. Pathology Genetics. Tumours of the Nervous System. Lyon: IARC Press; 2000 Kleiman G, Hochberg F, Richardson E. Systemic metastases from medulloblastoma: Report of two cases and review of the literature. Cancer 1984; 48: 2296-2309 Kochi M, Kuratsu JI, Mihara Y, et al. Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chlorethyl)-1-nitrosurea hydrochloride. Neurosurgery 1993; 33 (5): 817-823 Kortmann RD, Timmermann B, Becker G, et al. Advances in treatment techniques and time/dose schedules in external radiation therapy of brain tumours in childhood. Klin Pädiatr 1998; 210: 220-226 Kortmann RD, Becker G, Perelmouter J, et al. Geometric accuracy of field alignment in fractionated stereotactic conformal radiotherapy of brain tumors. Int J Radiat Oncol Biol Phys 1999; 43 (4): 921-926 Kortmann RD, Timmermann B, Kühl J, et al. HIT‘91 (prospective co-operative study for the treatment of malignant brain tumours in childhood): accuracy and acute toxicity of the irradiation of the craniospinal axis. Strahlenther Onkol 1999; 175 (4): 162-169 Kortmann, RD, Kühl J, Timmermann B, et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT’91. Int J Radiat Oncol Biol Phys 2000; 46 (2): 269-279 Kosch A, Mölenkamp G, Däumling E, et al. Assessment of independence in daily life in pediatric oncology by FMH-questionaire. Klin Pädiatr 1998; 210(6): 390-394 Kovalic JJ, Flaris N, Grigsby PW, et al. Intracranial ependymoma long term outcome, patterns of failure. J Neurooncol 1993; 15: 125-131 Kovnar E, Kun L, Krischer J. Patterns of dissemination and recurrence in childhood ependymoma: preliminary results of Pediatric Oncology Group protocol #8532. Ann Neurol 1991; 30: 457 (abstr) Kühl J, Müller HL, Berthold F, et al. Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT'88/'89. Klin Pädiatr 1998; 210: 227-233 Kühl J. Protokoll HIT 2000, Version vom 01.06.2000 Kun LE, Kovnar EH, Sanford RA. Ependymomas in children. Pediatr Neurosci 1988; 14: 57-63 Lefkowitz IB, Packer RJ, Ryan SG, et al. Late recurrence of primitive neuroectodermal tumor/medulloblastoma. Cancer 1988; 62: 826-830 Lefkowitz JB, Packer RJ, Siegel KR, et al. Results of treatment of children with recurrent primitive neuroectodermal tumors-medulloblastoma with lomustine, cisplatin and vincristine. Cancer 1990; 65: 412-417 Mahoney DHJ, Strother D, Camitta B, et al. High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study. J Clin Oncol 1996; 14: 382-388 Mason WP, Goldman S, Yates AJ, et al. Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma--a report of the Children's Cancer Group. J Neurooncol 1998; 37 (2): 135-143 Version 6: 10.03.2011, inkl. 3. Amendment McIntosh N. Medulloblastoma: a changing prognosis. Arch Dis Child 1979; 54: 200-203 Michon J, Schleiermacher G. Autologous haematopoietic stem cell transplantation for pediatric solid tumors. Bailllieres Best Pract Res Clin Haematol 1999; 12: 247-259 Milker-Zabel S, Zabel A, Thilmann C, et al. Results of three-dimensional stereotactically-guided radiotherapy in recurrent medulloblastoma. J Neurooncol 2002; 60 (3): 227-233 Müller HL, Frühwald MC, Scheubeck M, et al. A possible role for somatostatin receptor scintigraphy in the diagnosis and follow-up of children with medulloblastoma. J Neurooncol. 1998; 38 (1): 27-40 Müller HL, Bueb K, Bartels U, et al. Obesity after childhood craniopharyngioma - German multicenter study on preoperative risk factors and quality of life. Klin Pädiatr 2001; 213(4): 244-249 Needle MN, Goldwein JW, Grass J, et al. Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Cancer 1997a; 80: 341-347 Needle MN, Molloy PT, Geyer JR, et al. Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors. Med Pediatr Oncol 1997b; 29 (1): 28-32 Newton HB, Henson J, Walker RW. Extraneural metastases in ependymoma. J Neurooncol 1992; 14: 135-142 nQuery Advisor, Version 3.0. Statistical Solutions Ltd., Cork, Ireland. O'Brien P, Fleming T. A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549-556 Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., Carbone, P.P.: Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982. O'Reilly SM, Newlands ES, Glaser MG, et al. Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours. Eur J Cancer 1993; 29° (7): 940-942 Packer RJ, Sutton LN, Eltermann R, et al. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 1994; 81: 690-698 Patrice SJ, Tarbell NJ, Goumnerova LC, et al. Results of radiosurgery in the management of recurrent and residual medulloblastoma. Pediatr Neurosurg 1995; 22 (4): 197-203 Pendergrass TW, Milstein JM, Geyer JR, et al. Eight drugs in one day chemotherapy for brain tumors: Experience in 107 children and rationale for preradiation chemotherapy. J Clin Oncol 1987; 5: 1221-1231 Postmus PE, Holthuis JJ, Haaxma-Reiche H, et al. Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration. J Clin Oncol 1984; 2: 215-220 Riccardi R, Cefalo G, Ruggiero A, et al. High response rate to temozolomide in heavily pretreated children with medulloblastoma. Proceedings of 93rd Annual Meeting AACR 2002, 43: abstr 3711 Rosen G, Ghavimi F, Nirenberg A, et al. High-dose methotrexate with citrovorum factor rescue for the treatment of central nervous system tumors in children. Cancer Treat Rep 1977; 61: 781-790 Rousseau P, Habrand JL, Sarrazin D, et al. Treatment of intracranial ependymomas of children: review of 15-year experience. J Radiat Oncol Biol Phys 1994; 28: 381-386 Rubinstein LJ. Justification for a cytogenetic scheme of embyronal central neuroepithelial tumors. In: Fields WS (ed). Primary brain tumors. A review of histologic classification. Springer-Verlag, New York, 1989: 16-27 Rutkowski S, Bode U, Deinlein F, et al. Cure of children less than three years with medulloblastoma (M0/M1-stage) by postoperative chemotherapy only: final results of the HIT-SKK’92 Study. 11th International Symposium on Pediatric Neuro-Oncology, Boston, June 13th-16th, 2004 (abstr) Rutkowski S, Bode U, Deinlein F, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med. 2005; 352(10): 978-986 Santana VM, Schell MJ, Williams R, et al. Escalating sequential high-dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors. Bone Marrow Transplant 1992; 10: 457-462 Savaraj N, Lu K, Feun LG, et al. Comparison of CNS penetration, tissue distribution, and pharmacology of VP 16-213 by intracarotid and intravenous administration in dogs. Cancer Invest 1987; 5: 11-16 Schäfer H, Müller HH. Modification of the sample size and the schedule of interim analyses in survival trials based on data inspections. Statistics in Medicine 2001; 20: 3741-3751 Scheurlen WG, Schwabe GC, Joos S, et al. Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome. J Clin Oncol 1998; 16 (7): 2478-2485 Version 6: 10.03.2011, inkl. 3. Amendment Segal RA, Goumnerova LC, Kwon YK, et al. Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci USA 1994; 91 (26): 12867-12871 Shapiro WR. Chemotherapy of primary malignant brain tumors in children. Cancer 1975; 35(3 suppl): 965-972 Shepherd SF, Laing RW, Cosgrove VP, et al. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys 1997; 37 (2): 393-398 Simon A, Fleischhack G. Nicht medikamentöse Infektionsprophylaxe in der pädiatrischen Hämatologie-Onkologie. Klin Pädiatr 2001; 213 Sonderheft 1: A9-A21 Simon A, Fleischhack G, Marklein G, et al. Chemoprophylaxe bakterieller Infektionskrankheiten in der pädiatrischen Onkologie. Klin Pädiatr 2001; 213 Sonderheft 1: A22-A37 Simon R. Optimal two stage designs for phase II clinical trials. Controlled Clinical Trials 1989; 10: 1-10 Stafford SL, Pollock BE, Foote RL, et al. Stereotactic radiosurgery for recurrent ependymoma. Cancer 2000; 88 (4): 870-875 Sterba J, Pavelka Z, Slampa P. Concomitant radiotherapy and metronomic temozolomide in pediatric high-risk brain tumors. Neoplasma 2002; 49 (2): 117-120 Stremetzne S, Jaehde U, Schunack W. Determination of the cytotoxic catechol metabolite of etoposide (3'O-demethyletoposide) in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1997; 703: 209-215 Strother D, Ashley D, Kellie SJ, et al. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study. J Clin Oncol 2001; 19 (10): 2696-2704 Suh JH, Barnett GH. Stereotactic radiosurgery for brain tumors in pediatric patients. Technol Cancer Res Treat 2003; 2 (2): 141-146 Sur P, Sribnick EA, Patel SJ, Ray SK, Banik NL. Dexamethasone decreases temozolomide-induced apoptosis in human gliobastoma T98G cells. Glia 2005; 50(2): 160-167 Tait DM, Thorton-Jones H, Bloom HJG, et al. Adjuvant chemotherapy for medulloblastoma: The first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 1990; 26: 464-447 Taylor RE. Review of radiotherapy dose and volume for intracranial ependymoma. Pediatr Blood Cancer 2004; 42 (5): 457-460 Timmermannn B, Kortmann RD, Kühl J, et al. Combined postoperative irradiation and chemotherapy for anaplstic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91. Int J Radiat Oncol Biol Phys 2000; 46: 287-295 Timmermannn B, Kortmann RD, Kühl J, et al. Postoperative therapy of ependymoma in children: results of the German HIT-SKK and HIT trials. Med Pediatr Oncol 2002; 39: 249 Tomlinson FH, Lihou MG, Smith PJ. Comparison of in vitro activity of epipodophyllotoxins with other chemotherapeutic agents in human medulloblastomas. Br J Cancer 1991; 64: 1051-1059 Torres CF, Rebsamen S, Silber JH, et al. Surveillance scanning of children with medulloblastoma. N Engl J Med 1994; 330: 892-895 Trimis G, Prodromou F, Sfakianos G, et al. Temozolomide in malignant CNS Neoplasms of Childhood: a single institution experience. Pediatr Blood Cancer 2004, 43 (4): 401 (abstr) van der Gaast A, Sonneveld P, Mans DR, et al. Intrathecal administration of etoposide in the treatment of malignant meningitis: feasibility and pharmacokinetic data. Cancer Chemother Pharmacol 1992; 29: 335-337 van Veelen-Vincent ML, Pierre-Kahn A, Kalifa C, et al. Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy. J Neurosurg 2002; 97: 827-835 Vera K, Djafari L, Faivre S, et al. Dose-dense regimen of temozolomide given every other week in patients with primary central nervous system tumors. Ann Oncol 2004; 15 (1): 161-171 Verschraegen CF, Jaeckle K, Giovanella B, et al. Alternative administration of camptothecin analogues. Ann N Y Acad Sci 2000; 922: 237-246 Wagner S, Erdlenbruch B, Längler A, et al. Oral topotecan in children with recurrent or progressive high-grade glioma: a Phase I/II study by the German Society for Pediatric Oncology and Hematology. Cancer 2004; 100 (8): 1750-1757 Wald, A. Sequential tests of statistical hypotheses. Annals of Mathematical Statistics 1945; 16: 117-186. Version 6: 10.03.2011, inkl. 3. Amendment Walker RW, Allen JC. Cisplatin in the treatment of recurrent childhood primary brain tumors. J Clin Oncol 1988; 6: 62-66 Warmuth-Metz M, Kühl J, Bendzus M., et al. Die Inzidenz von Marklagerveränderungen bei hochdosierter Methotrexat-Gabe bei Kindern mit Medulloblastomen unter 3 Jahren: Vorläufige Ergebnisse der HIT-SKK-Studien. Aktuelle Neuropädiatrie 1998, Herausgeber: Bentele und Kohlschütter, 1998: 77-82 Wassmer G., Eisebitt R. Institut for Medical Statistics, University of Cologne, Clin Research GmbH, Cologne, Version 2.1.4, January 2004. Wolff JE, Molenkamp G, Westphal S, et al. Oral trofosfamide and etoposide in pediatric patients with glioblastoma multiforme. Cancer 2000; 89 (10): 2131-2137 Wolff JE, Westphal S, Molenkamp G, et al. Treatment of paediatric pontine glioma with oral trophosphamide and etoposide. Br J Cancer 2002; 87 (9): 945-949 Woo C, Stea B, Lulu B, Hamilton A, Cassady JR. The use of stereotactic radiosurgical boost in the treatment of medulloblastomas. Int J Radiat Oncol Biol Phys 1997; 37 (4): 761-764 Young JL, Miller W. Incidence of malignant tumors in U.S. children. J Pediatr 1975; 86: 254-258 Zernikow B, Griessinger N, Fengler R. [Practice of pain control in paediatric oncology--recommendations of the quality-monitoring group of the German Society for Paediatric Oncology and Haematology (GPOH)] Schmerz 1999; 13(3): 213-235 Zia MI, Forsyth P, Chaudhry A, et al. Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma. Bone Marrow Transplant 2002; 30 (9): 565-569 Ziegler A, Lange S, Bender R. Überlebenszeitanalyse: Der Log-Rang-Test. Dtsch Med Wochenschr 2004; 129: T4-T6 Version 6: 10.03.2011, inkl. 3. Amendment

Source: http://www.kinderkrebsstiftung.de/fileadmin/kinderkrebsinfo.de/HIT-REZ_2005_v6Amend3_Literaturverzeichnis_ger.pdf